🔗 Permalink

Inventor profile of:

André Pelegrin

City:

Montpellier

Country:

France

Published Applications:

Last publication date:

2022-10-13

Top Assignees for applications by André Pelegrin

The entities that hold a legal rights for patent applications filed by inventor Pelegrin André:

INSERM INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) 6 Paris, France
Institut National De La Sante Et De La Recherche Medicale (INSERM) 5 Paris, France
Université De Montpellier 5 Montpellier, France
Institut Regional du Cancer de Montpellier 3 Montpellier, France
Institut Paoli Calmettes 2 Marseilles, France
Centre National de la Recherche Scientifique (CNRS 2 Paris, France
Institut Regional du Cancer de Montpellier-Val d'Aurelle 2 Montpellier, France
UNIVERSITE DE MONTPELLIER 1 2 MONTPELLIER CEDEX, France
UNIVERSITE D'AIX-MARSEILLE 2 Marseilles, France
OriBase Pharma 2 Montpellier Cedex 4, France
UNIVERSITE DE MONTPELLIER 1 2 Montpellier Cedex 6, France
Institut Regional du Cancer de Montpellier-Val d' Aurelle 1 Montpellier Cedex, France
UNIVERSITE MONTPELLIER I 1 Montpellier Cedex, France
GAMAMABS PHARMA 1 Toulouse, France
UNIVERSITE De Montpellier 1 1 , France
CENTRE VAL D'AURELLE - PAUL LAMARQUE 1 Montpellier Cedex 5, France
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE -CNRS 1 Paris Cedex, France
Gamamabs Pharma SA 1 Toulouse Cedex 1, France
Institut Regional du Cancer de Montpellier-Val d' Aurelle 1 Montpellier Cedex 5, France
L'Institut National de la Sante et de la Recherche Medicale 1 Paris, France
INSTITUT Regional Du Cancer De Montpellier-Val D'Aurelle 1 , France
INSERM (Institut National de la Santé et de la Recherche Médicale) 1 , France
Institut National de la Sante et de la Recherche Medicale (INSERM) 1 Paris Cedex, France
ORIBASE Pharma 1 , France
INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE- INSERM 1 Paris, France
ORIBASE PHARMA 1 Montpellier Cedex, France
Centre Regional de Lutte Contre le Cancer “Val d'Aurelle-Paul Lamarque” 1 Montpellier Cedex, France
UNIVERSITE DE MONTPELLIER 1 1 Montpellier Cedex 2, France
Centre Val d'Aurelle—Paul Lamarque 1 Montpellier Cedex, France
INSERM (INSTITUT NATIONALDE LA SENTE ET DE LA RECHERCHE MEDICALE) 1 Paris, France
Institut Regional du Cancer de Montpellier-Val d'Aurelle 1 Montpellier Cedex 5, France
SORBONNE UNIVERSITE 1 Paris, France

Recent patent applications by Pelegrin André

André Pelegrin from Montpellier, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-10-13

US20220324962A1

Chemistry; metallurgy

ANTI-MÜLLERIAN INHIBITING SUBSTANCE ANTIBODIES AND USES THEREOF

#2 | 2022-09-15

US20220290151A1

Chemistry; metallurgy

USE OF MÜLLERIAN INHIBITING SUBSTANCE INHIBITORS FOR TREATING CANCER

#3 | 2018-06-07

US20180155433A1

Chemistry; metallurgy

Anti-human-HER3 antibodies and uses thereof

#4 | 2016-11-03

US20160319033A1

Chemistry; metallurgy

Neuregulin allosteric anti-HER3 antibody

#5 | 2016-03-24

US20160083476A1

Chemistry; metallurgy

Production of antibody formats and immunological applications of said formats

#6 | 2015-05-14

US20150132308A1

Chemistry; metallurgy

Combination therapy using anti-EGFR and anti-HER2 antibodies

#7 | 2014-10-09

US20140302041A1

Chemistry; metallurgy

Anti-Axl antibodies and uses thereof

#8 | 2014-08-14

US20140227283A1

Chemistry; metallurgy

Anti-Axl antibodies and uses thereof

#9 | 2014-05-22

US20140141019A1

Chemistry; metallurgy

Antibodies against HER3

#10 | 2014-04-24

US20140112931A1

Chemistry; metallurgy

Anti-human HER3 antibodies and uses thereof

#11 | 2013-06-27

US20130164300A1

Chemistry; metallurgy

Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type II receptor (AMHR-II)

#12 | 2012-12-06

US20120308477A1

Human necessities

BRIEF RADIOIMMUNOTHERAPY

#13 | 2011-05-12

US20110110929A1

Chemistry; metallurgy

HUMAN ANTI-IDIOTYPIC ANTIBODY FRAGMENTS THAT MIMIC HER-2/NEU

#14 | 2010-06-03

US20100135996A1

Chemistry; metallurgy

Monoclonal antibodies and fragment thereof directed against the human Anti-Müllerian Hormone type II receptor (AMHR-II)

#15 | 2009-08-27

US20090214541A1

Chemistry; metallurgy

Combination Therapy Using Anti-EGFR and Anti-HER2 Antibodies

#16 | 2009-08-13

US20090202979A1

Chemistry; metallurgy

Production of antibody formats and immunological applications of said formats

#17 | 2007-12-27

US20070298033A1

Chemistry; metallurgy

Human anti-idiotypic antibody fragments that mimic HER-2/neu

InventorID:

311459 ⎘